Publications by authors named "J P Bizzari"

Claim this Profile
L
Lenalidomide in multiple myeloma: current role and future directions.
Jerome B Zeldis, Robert D Knight, Christian Jacques, Alison Tozer, Jean-Pierre Bizzari

Expert Opin Pharmacother· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Oncology 2003: new therapeutic perspectives].
Jean-Pierre Bizzari

Med Sci (Paris)· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer.
T Le Chevalier, J Bérille, J R Zalcberg, M J Millward, A Monnier, J P Bizzari

Semin Oncol· June 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel in the community setting: an analysis of 377 breast cancer patients treated with docetaxel (Taxotere) in the UK. UK Study Group.
M E O'Brien, R C Leonard, P J Barrett-Lee, S P Eggleton, J P Bizzari

Ann Oncol· February 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined treatment with dacarbazine, cisplatin, fotemustine and tamoxifen in metastatic malignant melanoma.
M A Richard, J J Grob, H Zarrour, N Bassères, J P Bizzari

Melanoma Res· April 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis